Terms: = Colorectal cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Clinical Outcome
20 results:
1. Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer.
Zhu H; Roelands J; Ahmed EI; Stouten I; Hoorntje R; van Vlierberghe RLP; Ijsselsteijn ME; Lei X; de Miranda NFCC; Tollenaar RAEM; Vahrmeijer AL; Bedognetti D; Hendrickx WRL; Kuppen PJK
Front Immunol; 2024; 15():1293618. PubMed ID: 38375478
[TBL] [Abstract] [Full Text] [Related]
2. Systemic Inflammation Associates With a Myeloid Inflamed Tumor Microenvironment in Primary Resected Colon cancer-May Cold Tumors Simply Be Too Hot?
Køstner AH; Nielsen PS; Georgsen JB; Parner ET; Nielsen MB; Kersten C; Steiniche T
Front Immunol; 2021; 12():716342. PubMed ID: 34531864
[TBL] [Abstract] [Full Text] [Related]
3. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon cancer via Inhibiting Immune Tolerance.
Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454
[TBL] [Abstract] [Full Text] [Related]
4. Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the clinical outcome in colorectal cancer.
Waniczek D; Lorenc Z; Śnietura M; Wesecki M; Kopec A; Muc-Wierzgoń M
Arch Immunol Ther Exp (Warsz); 2017 Oct; 65(5):445-454. PubMed ID: 28343267
[TBL] [Abstract] [Full Text] [Related]
5. Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response.
McCoy MJ; Hemmings C; Anyaegbu CC; Austin SJ; Lee-Pullen TF; Miller TJ; Bulsara MK; Zeps N; Nowak AK; Lake RA; Platell CF
Oncotarget; 2017 Mar; 8(12):19803-19813. PubMed ID: 28177891
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNA let-7, T Cells, and Patient Survival in colorectal cancer.
Dou R; Nishihara R; Cao Y; Hamada T; Mima K; Masuda A; Masugi Y; Shi Y; Gu M; Li W; da Silva A; Nosho K; Zhang X; Meyerhardt JA; Giovannucci EL; Chan AT; Fuchs CS; Qian ZR; Ogino S
Cancer Immunol Res; 2016 Nov; 4(11):927-935. PubMed ID: 27737877
[TBL] [Abstract] [Full Text] [Related]
7. Low stromal foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer.
McCoy MJ; Hemmings C; Miller TJ; Austin SJ; Bulsara MK; Zeps N; Nowak AK; Lake RA; Platell CF
Br J Cancer; 2015 Dec; 113(12):1677-86. PubMed ID: 26645238
[TBL] [Abstract] [Full Text] [Related]
8. A Novel Immune Marker Model Predicts Oncological outcomes of Patients with colorectal cancer.
Chen Y; Yuan R; Wu X; He X; Zeng Y; Fan X; Wang L; Wang J; Lan P; Wu X
Ann Surg Oncol; 2016 Mar; 23(3):826-32. PubMed ID: 26581202
[TBL] [Abstract] [Full Text] [Related]
9. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced colorectal cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).
Yoshida N; Kinugasa T; Miyoshi H; Sato K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y; Ohshima K
Ann Surg Oncol; 2016 Mar; 23(3):919-27. PubMed ID: 26564244
[TBL] [Abstract] [Full Text] [Related]
10. High intratumoral foxp3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer.
Hanke T; Melling N; Simon R; Sauter G; Bokemeyer C; Lebok P; Terracciano LM; Izbicki JR; Marx AH
Int J Clin Exp Pathol; 2015; 8(7):8227-35. PubMed ID: 26339391
[TBL] [Abstract] [Full Text] [Related]
11. Leukocyte mitochondrial DNA content: a novel biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
Qu F; Chen Y; Wang X; He X; Ren T; Huang Q; Zhang J; Liu X; Guo X; Gu J; Xing J
Carcinogenesis; 2015 May; 36(5):543-52. PubMed ID: 25823896
[TBL] [Abstract] [Full Text] [Related]
12. Immunoprofiling for prognostic assessment of colon cancer: a novel complement to ultrastaging.
Lavotshkin S; Jalas JR; Torisu-Itakura H; Ozao-Choy J; Lee JH; Sim MS; Stojadinovic A; Wainberg Z; Bifulco CB; Fox BA; Bilchik AJ
J Gastrointest Surg; 2015 Jun; 19(6):999-1006. PubMed ID: 25808375
[TBL] [Abstract] [Full Text] [Related]
13. CD8+ and foxp3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.
Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864
[TBL] [Abstract] [Full Text] [Related]
14. Digital pattern recognition-based image analysis quantifies immune infiltrates in distinct tissue regions of colorectal cancer and identifies a metastatic phenotype.
Angell HK; Gray N; Womack C; Pritchard DI; Wilkinson RW; Cumberbatch M
Br J Cancer; 2013 Sep; 109(6):1618-24. PubMed ID: 23963148
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic impact of foxp3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas.
Yoon HH; Orrock JM; Foster NR; Sargent DJ; Smyrk TC; Sinicrope FA
PLoS One; 2012; 7(8):e42274. PubMed ID: 22879926
[TBL] [Abstract] [Full Text] [Related]
16. T cell subpopulations in lymph nodes may not be predictive of patient outcome in colorectal cancer.
Kemp RA; Black MA; McCall J; Yoon HS; Phillips V; Anjomshoaa A; Reeve AE
J Exp Clin Cancer Res; 2011 Aug; 30(1):78. PubMed ID: 21864372
[TBL] [Abstract] [Full Text] [Related]
17. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.
Nosho K; Baba Y; Tanaka N; Shima K; Hayashi M; Meyerhardt JA; Giovannucci E; Dranoff G; Fuchs CS; Ogino S
J Pathol; 2010 Dec; 222(4):350-66. PubMed ID: 20927778
[TBL] [Abstract] [Full Text] [Related]
18. Regulatory (foxp3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.
Correale P; Rotundo MS; Del Vecchio MT; Remondo C; Migali C; Ginanneschi C; Tsang KY; Licchetta A; Mannucci S; Loiacono L; Tassone P; Francini G; Tagliaferri P
J Immunother; 2010 May; 33(4):435-41. PubMed ID: 20386463
[TBL] [Abstract] [Full Text] [Related]
19. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
Zlobec I; Lugli A
World J Gastroenterol; 2009 Dec; 15(47):5898-906. PubMed ID: 20014453
[TBL] [Abstract] [Full Text] [Related]
20. Intraepithelial effector (CD3+)/regulatory (foxp3+) T-cell ratio predicts a clinical outcome of human colon carcinoma.
Sinicrope FA; Rego RL; Ansell SM; Knutson KL; Foster NR; Sargent DJ
Gastroenterology; 2009 Oct; 137(4):1270-9. PubMed ID: 19577568
[TBL] [Abstract] [Full Text] [Related]
